Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30,210,911
-
Total 13F shares
-
16,260,263
-
Share change
-
-59,137
-
Total reported value
-
$323,227,753
-
Put/Call ratio
-
13%
-
Price per share
-
$19.88
-
Number of holders
-
165
-
Value change
-
+$1,152,439
-
Number of buys
-
78
-
Number of sells
-
79
Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2025
As of 30 Jun 2025,
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,260,263 shares.
The largest 10 holders included
BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
165
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.